GHRH and lung carcinoma: Other laboratories have also clearly shown the converse that GHRH antagonists powerfully inhibit angiogenesis and growth of lung cancer cells [21], prostate cancer cells [22], glioblastomas cells [23], and breast cancer cells [24].